Novel anticancer and wound healing pharmaceuticals for human and veterinary markets – discovery, development and commercialisation.

We discover and develop plant-derived cell signalling molecules to address challenging medical conditions in humans and companion animals.

The simultaneous development of products for both veterinary and human application enables early validation of technology, reducing risks for human development, while generating early revenues through quicker to market veterinary products.